Morbelli, Silvia
Esposito, Giuseppe
Arbizu, Javier
Barthel, Henryk
Boellaard, Ronald
Bohnen, Nico I.
Brooks, David J
Darcourt, Jacques
Dickson, John C.
Douglas, David
Drzezga, Alexander
Dubroff, Jacob
Ekmekcioglu, Ozgul
Garibotto, Valentina
Herscovitch, Peter
Kuo, Phillip
Lammertsma, Adriaan
Pappata, Sabina
Peñuelas, Iván
Seibyl, John
Semah, Franck
Tossici-Bolt, Livia
Van de Giessen, Elsmarieke
Van Laere, Koen
Varrone, Andrea
Wanner, Michele
Zubal, George
Law, Ian
Article History
Received: 20 February 2020
Accepted: 6 April 2020
First Online: 9 May 2020
Compliance with ethical standards
:
: Silvia Morbelli has received speaker honoraria from GE Healthcare and Eli-Lilly; Javier Arbizu has received research grants from Lilly-Avid, General Electric Healthcare, and Piramal and speaker honoraria from Biogen, Araclon Biotech-Grifols, Bayer, and Novartis; Ronald Boellaard has provided data analysis service for Bristol Meyers Squibb, Rodin, and Roche and is a scientific advisor for EARL; Nico Bohnen has received research support from the NIH, Department of Veteran Affairs, the Michael J. Fox Foundation, Eisai, Axovant Sciences, and Chase Pharmaceuticals; David Brooks was consultant for GE Healthcare and Biogen; John C. Dickson was consultant for GE Healthcare, Bioclinica, and Biogen; Alexander Drzezga has received speaker honoraria from Siemens Healthineers, Sanofi, and Henning and received research support from AVID/Lilly, Life Molecular Imaging, GE Healthcare, and Siemens Healthineers; Jacob Dubroff received speaker honoraria from IBA; Peter Herscovitch is a member of Medical Imaging Drug Advisory Committee of US Food and Drug Administration; John Seibyl is consultant for Invicro, Biogen, Roche, Life Molecular Imaging, and LikeMinds and has equity holding of Invicro; K. Van Laere has performed consultancy services and contract research, through KU Leuven, for GE Healthcare, Merck, Janssen Pharmaceuticals, UCB, Syndesi Therapeutics, and Eikonizo; Ian Law has received speaker honoraria from Siemens Healthcare. The other authors declare no conflict of interest.
: These guidelines do not contain any studies with human participants or animals performed by any of the authors.
: This guideline summarizes the views of the EANM Neuroimaging and Dosimetry Committees and SNMMI. It reflects recommendations for which the EANM and the SNMMI cannot be held responsible. The recommendations should be taken into context of good practice of nuclear medicine and do not substitute for national and international legal or regulatory provisions.